0,926  0,003  CYP1A2 inhibitor
0,899  0,003  Caspase 9 stimulant
0,898  0,002  Antimutagenic
0,847  0,003  AR expression inhibitor
0,850  0,011  Apoptosis agonist
0,804  0,004  Free radical scavenger
0,782  0,004  Caspase 3 stimulant
0,772  0,004  CTGF expression inhibitor
0,773  0,010  Antineoplastic (lung cancer)
0,759  0,003  Breast cancer-resistant protein inhibitor
0,768  0,012  Antineoplastic (breast cancer)
0,759  0,005  Antioxidant
0,757  0,008  Antileukemic
0,726  0,008  Prostate cancer treatment
0,716  0,005  NOS2 expression inhibitor
0,714  0,006  UGT1A9 substrate
0,700  0,002  Cystathionine beta-synthase inhibitor
0,696  0,005  Cardioprotectant
0,691  0,009  CYP1A2 substrate
0,677  0,010  Aryl hydrocarbon receptor agonist
0,669  0,006  UGT1A6 substrate
0,666  0,012  Chemoprotective
0,643  0,004  GABA C receptor rho-3 antagonist
0,646  0,010  Antineoplastic (cervical cancer)
0,653  0,018  TNF expression inhibitor
0,640  0,004  P-glycoprotein inhibitor
0,627  0,007  Amyloid beta aggregation inhibitor
0,625  0,007  Antiprotozoal (Leishmania)
0,634  0,020  Antineoplastic (colorectal cancer)
0,622  0,007  CYP2C19 inhibitor
0,618  0,004  Peroxidase inhibitor
0,617  0,009  5 Hydroxytryptamine release inhibitor
0,620  0,012  12-Lipoxygenase inhibitor
0,621  0,016  Aldehyde oxidase inhibitor
0,621  0,020  Antineoplastic (colon cancer)
0,607  0,009  Histamine release inhibitor
0,596  0,007  Superoxide dismutase inhibitor
0,592  0,004  NADPH oxidase inhibitor
0,589  0,012  NOS3 expression inhibitor
0,572  0,005  UGT1A3 substrate
0,575  0,015  Chemopreventive
0,608  0,052  Alpha-glucosidase inhibitor
0,564  0,011  Antineoplastic (glioma)
0,582  0,033  Transcription factor NF kappa B inhibitor
0,549  0,006  MAO inhibitor
0,554  0,014  Ulceration
0,542  0,007  Antihypoxic
0,542  0,008  UGT1A1 substrate
0,541  0,009  Vascular (periferal) disease treatment
0,542  0,011  Vasodilator, coronary
0,561  0,030  15-Lipoxygenase inhibitor
0,548  0,018  Antineoplastic (melanoma)
0,544  0,016  Cytostatic
0,532  0,005  MAO A inhibitor
0,585  0,058  Antiinflammatory
0,531  0,004  UGT2B15 substrate
0,542  0,019  Radioprotector
0,529  0,012  Tumour necrosis factor alpha release inhibitor
0,530  0,019  CYP2C9 inhibitor
0,514  0,010  Antihypertriglyceridemic
0,508  0,007  Skin whitener
0,515  0,017  Lipoxygenase inhibitor
0,505  0,012  Vasodilator
0,500  0,007  Antineoplastic (squamous cell carcinoma)
0,504  0,014  Antineoplastic (glioblastoma multiforme)
0,494  0,003  Antihemorrhagic
0,499  0,012  ICAM1 expression inhibitor
0,498  0,014  DNA damaging
0,485  0,004  Xanthine oxidase inhibitor
0,495  0,019  Proliferative diseases treatment
0,474  0,005  Acetylcholinesterase inhibitor
0,490  0,022  Apoptosis antagonist
0,475  0,013  UDP-glucuronosyltransferase substrate
0,477  0,018  Nitric oxide antagonist
0,467  0,010  Antineoplastic (carcinoma)
0,474  0,018  Hypoglycemic
0,450  0,009  Monophenol monooxygenase inhibitor
0,455  0,015  Antineoplastic (liver cancer)
0,444  0,005  Glyceraldehyde-3-phosphate dehydrogenase inhibitor
0,466  0,028  Hepatic disorders treatment
0,442  0,005  Interleukin 4 antagonist
0,446  0,010  Tubulin antagonist
0,451  0,020  Hypoxia-inducible factor 1 alpha inhibitor
0,457  0,027  Antineoplastic (pancreatic cancer)
0,469  0,043  CYP2C9 substrate
0,432  0,009  Genotoxic
0,426  0,004  Carbonic anhydrase XIII inhibitor
0,444  0,025  Antineoplastic (non-small cell lung cancer)
0,463  0,045  Antipruritic, allergic
0,432  0,015  RNA-directed DNA polymerase inhibitor
0,431  0,014  Antineoplastic (small cell lung cancer)
0,463  0,046  Antiprotozoal
0,437  0,022  UGT2B4 substrate
0,464  0,050  Prostaglandin dehydrogenase inhibitor
0,420  0,009  GST M1-1 substrate
0,446  0,035  Antineoplastic (ovarian cancer)
0,442  0,032  Spasmolytic
0,420  0,011  Melanin inhibitor
0,438  0,030  Antineoplastic (brain cancer)
0,411  0,005  Topoisomerase II alpha inhibitor
0,414  0,009  Amylase inhibitor
0,429  0,024  Antiamyloidogenic
0,421  0,018  Antineoplastic (osteosarcoma)
0,413  0,012  5 Hydroxytryptamine uptake stimulant
0,410  0,012  Hepatoprotectant
0,412  0,014  Antineoplastic (bladder cancer)
0,400  0,005  Alkaline phosphatase inhibitor
0,428  0,037  CYP2C19 substrate
0,399  0,008  NOS3 expression enhancer
0,400  0,010  Topoisomerase II inhibitor
0,409  0,019  Antineoplastic enhancer
0,393  0,004  Nitric-oxide synthase stimulant
0,397  0,008  Protein kinase stimulant
0,406  0,025  Cardiodepressant
0,387  0,010  Cholinergic
0,402  0,027  Antiprotozoal (Trypanosoma)
0,372  0,003  Multidrug resistance-associated protein 1 inhibitor
0,378  0,017  Dual specificity phosphatase inhibitor
0,373  0,015  Antihypotensive
0,391  0,034  CYP3A4 inhibitor
0,358  0,004  GABA C receptor rho-2 antagonist
0,377  0,025  Pyruvate kinase inhibitor
0,360  0,009  Tumour necrosis factor antagonist
0,361  0,011  Protein-tyrosine phosphatase inhibitor
0,358  0,009  Cytokine production inhibitor
0,352  0,004  Aldose reductase inhibitor
0,394  0,047  FMO1 substrate
0,347  0,004  Creatine kinase inhibitor
0,351  0,009  MAO B inhibitor
0,349  0,013  Lipid peroxidase inhibitor
0,348  0,014  DNA methyltransferase I inhibitor
0,346  0,013  Antineoplastic (gastric cancer)
0,353  0,020  Dual specificity phosphatase 3 inhibitor
0,347  0,014  Pneumotoxic
0,329  0,004  NAD(P)H dehydrogenase (quinone) inhibitor
0,328  0,004  Histone deacetylase SIRT1 stimulant
0,328  0,004  Histone deacetylase stimulant
0,374  0,050  CYP2D6 substrate
0,327  0,007  Gout treatment
0,322  0,004  VEGF expression inhibitor
0,328  0,012  CYP2B6 inhibitor
0,331  0,018  VCAM1 expression inhibitor
0,312  0,004  Antihelmintic (Trematoda)
0,341  0,034  Antimitotic
0,356  0,051  Antihypercholesterolemic
0,368  0,064  Antiprotozoal (Plasmodium)
0,311  0,010  Butyrylcholinesterase inhibitor
0,340  0,039  Antineoplastic (renal cancer)
0,323  0,022  DNA methylase inhibitor
0,338  0,038  Mutagenic
0,305  0,006  Telomerase inhibitor
0,328  0,030  Antineoplastic (sarcoma)
0,357  0,063  Bone diseases treatment
0,343  0,052  Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor
0,292  0,005  Gastritis treatment
0,292  0,006  Carbonic anhydrase III inhibitor
0,300  0,017  Amyloid beta precursor protein antagonist
0,301  0,021  Carcinogenic, group 3
0,289  0,009  LDLR expression enhancer
0,290  0,010  SULT1A3 substrate
0,288  0,009  Carbonic anhydrase XV inhibitor
0,332  0,055  Antiosteoporotic
0,351  0,078  CYP3A4 substrate
0,322  0,049  Antipyretic
0,391  0,123  DNA polymerase beta inhibitor
0,310  0,043  Carcinogenic
0,279  0,013  5-Lipoxygenase inhibitor
0,312  0,049  Transcription factor STAT inhibitor
0,359  0,097  Antibacterial
0,313  0,052  Sensitization
0,273  0,013  Protein-tyrosine phosphatase 1B inhibitor
0,286  0,027  Male reproductive disfunction treatment
0,301  0,043  Antiparasitic
0,294  0,036  Platelet adhesion inhibitor
0,267  0,014  Carcinogenic, group 1
0,255  0,004  Xanthine dehydrogenase inhibitor
0,258  0,008  Cyclooxygenase 3 inhibitor
0,256  0,008  Carbonic anhydrase VI inhibitor
0,279  0,037  Antihelmintic
0,259  0,018  UGT2B9 substrate
0,276  0,035  UGT1A4 substrate
0,287  0,054  Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor
0,261  0,028  Antiseptic
0,286  0,054  Cytotoxic
0,301  0,070  5 Hydroxytryptamine release stimulant
0,242  0,015  Phobic disorders treatment
0,231  0,004  Protease activated receptor antagonist
0,234  0,009  Beta glucuronidase inhibitor
0,251  0,027  3C-like protease (Human coronavirus) inhibitor
0,230  0,006  Electron transport complex I inhibitor
0,226  0,009  Photosensitizer
0,298  0,081  Antifungal
0,218  0,004  Carbonic anhydrase VII inhibitor
0,220  0,007  T cell inhibitor
0,253  0,041  UGT2B7 substrate
0,232  0,021  Antiviral (Ebola)
0,253  0,042  Non-steroidal antiinflammatory agent
0,238  0,029  Cyclooxygenase inhibitor
0,214  0,008  Antineoplastic (uterine cancer)
0,299  0,093  Calcium channel activator
0,283  0,077  Antineoplastic (multiple myeloma)
0,345  0,140  DNA directed DNA polymerase inhibitor
0,232  0,029  Succinate dehydrogenase inhibitor
0,215  0,015  SULT1A1 substrate
0,211  0,016  CF transmembrane conductance regulator agonist
0,199  0,005  Interleukin 5 antagonist
0,201  0,008  GABA C receptor rho-1 antagonist
0,220  0,028  Cyclooxygenase 1 inhibitor
0,233  0,045  Insulin sensitizer
0,257  0,070  Myocardial infarction treatment
0,256  0,069  Dyrk kinase inhibitor
0,251  0,066  Antineoplastic (lymphoma)
0,219  0,036  Proto-oncogene tyrosine-protein kinase Yes inhibitor
0,249  0,067  Antineoplastic (lymphocytic leukemia)
0,260  0,077  Radiosensitizer
0,195  0,014  Uric acid excretion stimulant
0,214  0,034  Antidote
0,207  0,027  Mannose-6-phosphate isomerase inhibitor
0,297  0,117  Immunosuppressant
0,208  0,029  Cyclooxygenase 2 inhibitor
0,209  0,031  M18 aspartyl aminopeptidase inhibitor
0,270  0,092  Streptokinase A inhibitor
0,249  0,073  Cardiovascular analeptic
0,183  0,007  Myeloperoxidase inhibitor
0,190  0,014  Phosphodiesterase IV inhibitor
0,179  0,004  D-Ala-D-Ala ligase inhibitor
0,278  0,104  Antiallergic
0,182  0,008  Cyclin B3 inhibitor
0,203  0,031  Hemostatic
0,244  0,073  Angiogenesis stimulant
0,186  0,015  Nav1.5 sodium channel blocker
0,177  0,009  SULT1E1 substrate
0,202  0,035  Bone formation stimulant
0,237  0,071  Cyclic AMP phosphodiesterase inhibitor
0,171  0,006  Thioredoxin reductase inhibitor
0,177  0,013  Heat shock protein 70 antagonist
0,314  0,150  Antidiabetic
0,314  0,150  Cyclophilin D inhibitor
0,316  0,152  Alzheimer's disease treatment
0,232  0,069  Interleukin antagonist
0,272  0,110  Antithrombotic
0,175  0,014  Phosphodiesterase 4D inhibitor
0,198  0,039  Heat shock protein 90 antagonist
0,168  0,010  Beta tubulin antagonist
0,168  0,010  CDC25A inhibitor
0,193  0,036  Antiprotozoal (Coccidial)
0,172  0,017  DNA repair enzyme inhibitor
0,278  0,123  GST A substrate
0,170  0,017  AMP-activated protein kinase stimulant
0,162  0,013  Antifungal (Pneumocystis)
0,152  0,004  Potassium channel Kv1.3 blocker
0,152  0,007  3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor
0,190  0,045  UGT2B10 substrate
0,163  0,019  Calcium antagonist
0,153  0,013  Aromatase inhibitor
0,159  0,019  Urease inhibitor
0,161  0,021  Dementia treatment
0,160  0,021  Sphingomyelinase inhibitor
0,254  0,116  Thyroid hormone beta antagonist
0,234  0,097  Transcription factor STAT3 inhibitor
0,156  0,019  Transcription factor STAT6 inhibitor
0,162  0,025  Papain-like protease (SARS coronavirus) inhibitor
0,146  0,010  Alpha tubulin antagonist
0,160  0,024  Sulfotransferase substrate
0,255  0,120  Thyroid hormone antagonist
0,153  0,020  DOPA decarboxylase inhibitor
0,227  0,094  Tyrosine 3 hydroxylase inhibitor
0,150  0,017  Thioredoxin inhibitor
0,148  0,016  Macrophage migration inhibitory factor inhibitor
0,154  0,022  Vascular dementia treatment
0,135  0,004  Glutamate (mGluR7) antagonist
0,157  0,026  GABA C receptor antagonist
0,169  0,038  Aldehyde dehydrogenase inhibitor
0,146  0,015  Carbonic anhydrase V inhibitor
0,135  0,006  Aryl hydrocarbon receptor antagonist
0,149  0,020  Protein kinase C zeta inhibitor
0,144  0,014  HIV-1 integrase (3'-Processing) inhibitor
0,142  0,013  HIV-1 integrase (Strand Transfer) inhibitor
0,161  0,034  Carcinogenic, group 2B
0,198  0,072  Histone acetyltransferase inhibitor
0,143  0,017  Estrogen receptor beta antagonist
0,161  0,036  Protein kinase (CK2) alpha inhibitor
0,158  0,034  Coagulant
0,148  0,024  Estrogen antagonist
0,137  0,014  Carbonic anhydrase VA inhibitor
0,163  0,040  Alkylator
0,190  0,068  Antiviral (Hepatitis)
0,173  0,054  Insulin secretagoues
0,155  0,037  Beta amyloid protein antagonist
0,139  0,022  Antiviral (SARS coronavirus)
0,139  0,022  Antiviral (Coronavirus)
0,155  0,039  Glutathione S-transferase substrate
0,193  0,077  Abortion inducer
0,194  0,079  Antiviral (Influenza)
0,179  0,064  Antineoplastic (bone cancer)
0,174  0,059  Acaricide
0,228  0,114  Respiratory analeptic
0,175  0,061  Antiviral (Hepatitis C)
0,117  0,004  Transcription factor RelA inhibitor
0,152  0,040  Topoisomerase I inhibitor
0,144  0,036  Choleretic
0,178  0,070  Antirickettsial
0,129  0,023  CYP2A6 inhibitor
0,114  0,008  Fatty acid synthase inhibitor
0,173  0,068  Heat shock protein 90 alpha antagonist
0,150  0,046  Antibacterial (Helicobacter pylori)
0,127  0,023  Interleukin 12 antagonist
0,121  0,017  Lipase inhibitor
0,224  0,122  Antiischemic
0,195  0,093  Antiulcerative
0,120  0,018  Estrogen receptor alpha antagonist
0,137  0,036  UGT2B1 substrate
0,155  0,055  Antifungal enhancer
0,124  0,025  Histidine decarboxylase inhibitor
0,150  0,050  Antiprotozoal (Trichomonas)
0,139  0,040  Chelator
0,105  0,009  CD45 antagonist
0,166  0,069  Interleukin 6 antagonist
0,114  0,020  Granulocyte macrophage colony stimulating factor agonist
0,168  0,075  Mcl-1 antagonist
0,290  0,197  Antineoplastic (solid tumors)
0,185  0,092  Neurotrophic factor enhancer
0,124  0,032  Alcohol dehydrogenase inhibitor
0,137  0,045  Contraceptive female
0,181  0,089  I kappa B kinase epsilon inhibitor
0,162  0,071  Cystic fibrosis treatment
0,096  0,005  GABA B receptor antagonist
0,157  0,068  Antiviral (Influenza A)
0,144  0,057  Toll-Like receptor 2 antagonist
0,183  0,097  5 Hydroxytryptamine 3E antagonist
0,207  0,123  5 Hydroxytryptamine 1E antagonist
0,126  0,042  Mediator release inhibitor
0,122  0,038  Antineoplastic antibiotic
0,108  0,024  Antiviral (Hepatitis A)
0,088  0,005  Ryanodine receptor antagonist
0,091  0,009  Postcoital contraceptive
0,085  0,004  Nucleoside transporters inhibitor
0,160  0,080  Neurotensin receptor agonist
0,158  0,079  Arachidonic acid antagonist
0,096  0,017  CDC25B inhibitor
0,198  0,120  Antiviral (West Nile virus)
0,105  0,028  mTOR complex 2 inhibitor
0,120  0,043  Toll-Like receptor 4 antagonist
0,103  0,026  Phosphodiesterase V inhibitor
0,114  0,038  Carcinogenic, group 2A
0,115  0,039  UGT2B11 substrate
0,190  0,116  Antidiabetic symptomatic
0,102  0,029  Keratolytic
0,141  0,069  Ca2+-transporting ATPase inhibitor
0,222  0,152  Vasodilator, peripheral
0,139  0,070  Toll-Like receptor 9 antagonist
0,080  0,011  Glucose-6-phosphate translocase inhibitor
0,198  0,129  Antituberculosic
0,097  0,028  Phosphodiesterase 5A inhibitor
0,127  0,060  Antitussive
0,118  0,051  HDL-cholesterol increasing
0,124  0,058  Antiviral (Influenza B)
0,086  0,020  Postmenopausal disorders treatment
0,081  0,016  Carbonic anhydrase XIV inhibitor
0,144  0,081  Phospholipase A2 inhibitor
0,156  0,093  Antipruritic, non-allergic
0,111  0,048  Antifungal (Aspergillus)
0,092  0,031  Adenosine A3 receptor antagonist
0,089  0,029  Phosphodiesterase VI inhibitor
0,079  0,019  Cyclin D1 inhibitor
0,146  0,088  Hearing loss treatment
0,073  0,015  Estradiol 17 beta-dehydrogenase inhibitor
0,083  0,024  Carbonic anhydrase XII inhibitor
0,203  0,147  Antimycobacterial
0,111  0,055  Protein kinase (CK2) inhibitor
0,110  0,055  GST T1-1 substrate
0,099  0,044  Glutamate release inhibitor
0,087  0,033  HIV-1 integrase inhibitor
0,166  0,113  Teratogen
0,099  0,046  Antidote, mercury
0,076  0,024  Estrogen agonist
0,112  0,062  Mucolytic
0,106  0,056  Cyclin-dependent kinase 9 inhibitor
0,097  0,048  Ornithine decarboxylase inhibitor
0,108  0,060  Expectorant
0,202  0,154  Insulysin inhibitor
0,240  0,194  Transcription factor inhibitor
0,089  0,043  Caspase 7 inhibitor
0,156  0,111  Psychostimulant
0,110  0,065  Acetylcholine release stimulant
0,115  0,070  Cholesterol synthesis inhibitor
0,074  0,030  Neuraminidase inhibitor
0,138  0,095  Neuropathy treatment
0,077  0,034  Leukotriene antagonist
0,118  0,076  Sphingosine 1-phosphate receptor 4 antagonist
0,137  0,097  Interferon gamma antagonist
0,103  0,063  Alpha 2c adrenoreceptor antagonist
0,096  0,056  ABCA1 expression enhancer
0,110  0,071  TRPA1 agonist
0,058  0,019  Leukocyte elastase inhibitor
0,095  0,057  Antiviral (Rhinovirus)
0,088  0,050  Inducible nitric-oxide synthase inhibitor
0,260  0,222  MAP kinase 1 inhibitor
0,071  0,034  Neuraminidase (influenza) inhibitor
0,099  0,062  Anticataract
0,090  0,055  Androgen antagonist
0,069  0,034  Antidote, heavy metal
0,064  0,032  Carbonic anhydrase VB inhibitor
0,162  0,131  Antialcoholic
0,054  0,024  Cholesterol esterase inhibitor
0,052  0,023  Benzodiazepine antagonist
0,117  0,089  Erectile dysfunction treatment
0,079  0,051  Na+ K+ transporting ATPase inhibitor
0,039  0,012  Estrogen-related receptor beta antagonist
0,071  0,045  Anticholelithogenic
0,145  0,119  Anesthetic general
0,099  0,074  Antiprotozoal (Toxoplasma)
0,102  0,078  Interleukin 1b antagonist
0,175  0,151  Analeptic
0,146  0,122  Embryotoxic
0,064  0,040  Phosphodiesterase 1C inhibitor
0,083  0,059  3C-Like protease (SARS coronavirus) inhibitor
0,043  0,020  Arginase inhibitor
0,086  0,063  Tocolytic
0,105  0,082  Microtubule formation inhibitor
0,057  0,036  Cyclin B2 inhibitor
0,164  0,143  Immunostimulant
0,103  0,083  Proteasome inhibitor
0,086  0,066  Actinic keratosis treatment
0,086  0,065  GST P1-1 substrate
0,195  0,175  Angiogenesis inhibitor
0,185  0,165  CYP2D6 inhibitor
0,055  0,035  Leukotriene B4 antagonist
0,032  0,012  Dopamine autoreceptor agonist
0,061  0,042  Cyclin B1 inhibitor
0,038  0,020  ATM kinase inhibitor
0,061  0,043  Transcription factor AP-1 inhibitor
0,052  0,034  Anesthetic inhalation
0,065  0,048  Leukotriene synthesis inhibitor
0,056  0,039  Leukotriene C antagonist
0,106  0,089  Retinopathy treatment
0,093  0,076  Glutamate (mGluR7) agonist
0,074  0,058  Narcotic antagonist
0,095  0,079  DNA intercalator
0,109  0,094  Antihyperlipoproteinemic
0,065  0,050  Female sexual dysfunction treatment
0,111  0,096  Antiviral (Papilloma)
0,103  0,089  Antiprotozoal (Babesia)
0,125  0,111  Hexokinase inhibitor
0,085  0,071  HIV-1 integrase (Overall Integration) inhibitor
0,083  0,070  Phosphodiesterase I inhibitor
0,039  0,025  Vanilloid 3 antagonist
0,062  0,049  Calcium channel P-type blocker
0,033  0,022  Protein kinase (CK2) beta inhibitor
0,039  0,029  Dopamine D5 agonist
0,025  0,014  Estradiol 17 beta-dehydrogenase 1 inhibitor
0,039  0,030  DNA-dependent protein kinase inhibitor
0,023  0,015  Monocarboxylic acid transporter inhibitor
0,023  0,015  Monocarboxylic acid transporter 1 inhibitor
0,014  0,006  Melatonin 2 antagonist
0,114  0,108  Psychosexual dysfunction treatment
0,117  0,110  Farnesoid X receptor antagonist
0,267  0,260  Ca2+/calmodulin-dependent protein kinase kinase A inhibitor
0,022  0,015  Estrone sulfatase inhibitor
0,037  0,031  Retinoic acid alpha receptor agonist
0,032  0,026  Melatonin receptor 1A agonist
0,080  0,074  NADH dehydrogenase inhibitor
0,031  0,026  Catechol O-methyltransferase inhibitor
0,060  0,056  Beta 3 adrenoreceptor antagonist
0,041  0,038  Fructose-1,6-bisphosphatase inhibitor
0,022  0,020  Fructose-1,6-bisphosphatase 1 inhibitor
0,064  0,062  Cathepsin G inhibitor
0,048  0,047  GABA receptor antagonist
0,137  0,136  Phospholipase C inhibitor
0,124  0,124  Liver fibrosis treatment

